Study to Assess the Safety and Patients' Satisfaction of Tears Again* in the Treatment of Dry Eye Symptoms

• Status: Completed
• Trial end date: 2010-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine safety and patients' satisfaction when using Tears Again to treat Dry Eye Symptoms.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Trima, Israel Pharmaceutical Products

Criteria

Inclusion Criteria:

• Suffer from at least two of the following ocular symptoms: burning, stinging, excessive tearing, dryness, grittiness, foreign body sensation ( including patients suffering from blepharitis).

• Use artificial tears or any other treatment for these symptoms three or more times a day.

Exclusion Criteria:

• Known hypersensitivity to Phenoxyethanol.

• Pregnant and lactating women.

• Receive other ophthalmic medication (except for eyelid hygiene preparations).

• Graft-versus-host disease patients.

• Participated during the last month in another clinical trial.